A predominance of R5-like HIV genotypes in vaginal secretions is associated with elevated plasma HIV-1 RNA levels and the absence of anti-retroviral therapy
2008

HIV Genotypes in Vaginal Secretions and Plasma Levels

Sample size: 43 publication Evidence: moderate

Author Information

Author(s): Randolph Tara C, Kissinger Patricia J, Clark Rebecca A, Lacour Nedra, Amedee Angela M

Primary Institution: Louisiana State University Health Sciences Center

Hypothesis

The study investigates the relationship between HIV genotypes in vaginal secretions and plasma HIV-1 RNA levels in women, particularly in relation to anti-retroviral therapy (ART) use.

Conclusion

The majority of women shedding R5-like HIV genotypes in vaginal secretions are at a higher risk of transmission, especially in the absence of ART.

Supporting Evidence

  • 67.4% of women shed R5-like genotypes in vaginal secretions.
  • R5-like genotypes were associated with elevated plasma HIV levels (≥ 10,000 copies HIV-RNA/mL).
  • X4-like genotypes were linked to lower plasma viral loads and the use of ART.

Takeaway

This study found that many women have a type of HIV in their vaginal secretions that can easily spread, especially if they are not taking medicine to control the virus.

Methodology

HIV-1 RNA levels were measured in vaginal secretions and plasma, and the V3 genotype of predominant variants in vaginal secretions was determined using heteroduplex tracking analyses.

Potential Biases

Potential biases may arise from self-reported ART use and the exclusion of blood-contaminated samples.

Limitations

The study did not conduct HTA analyses on matched plasma samples and had a limited sample size.

Participant Demographics

Cohort consisted of 43 women attending an HIV outpatient clinic in New Orleans.

Statistical Information

P-Value

0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1743-422X-5-87

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication